Stock exchanges & markets

Overview Watchlists

Lonza nominates Pearl Huang as independent board member

30. Sep 2026

(AWP Alliance News) - Lonza nominated Pearl Huang as an independent board member, subject to election at its May 2027 annual general meeting. Huang is set to join the Strategy and Innovation Committee, also the Remuneration Committee.

She currently serves as an independent director at Waters and BB Biotech, previously held senior roles at Roche, GSK, Merck, and was founder and chief scientific officer of Beigene, now BeOne Medicines. Lonza also said Angelica Kohlmann and Christoph Mäder will not stand for re-election at the 2027 AGM.

https://www.publicnow.com/view/2C26EB1FE5AA4FEE0A18E2A3F6A0C34BB2E7AB96…

Disclaimer: This news brief was created using generative artificial intelligence. Lonza Group Ltd. published the original content used to generate this news brief via EQS News on September 30, 2026, and is solely responsible for the information contained therein.

Learn more about our offers

  • Keep a close eye on your favourite shares

    Watchlist

    Don’t miss out on share price trends. Track your favourite shares (CH, EU & US) in real time with customised watchlists.

    Sign up now

  • Compare ETFs systematically

    ETF Compass

    Find the products that suit your investment goals.

    Try the ETF Compass

  • How to find the best shares

    theScreener

    Search through around 6,500 securities using criteria such as opportunities and risks or expected dividend yield.

    Test now